Bupa UK has announced it has launched a new remote skin assessment service which will help customers to detect skin cancers from home.
Dr Amy Poyner, a GP on the Isle of Wight, highlights how using teledermatology has ensured referrals continue as normal during the Covid-19 pandemic.
Experts found the apps may cause harm from failure to identify potentially deadly skin cancers, or from over-investigation such as removing harmless moles.
Researchers determined that the SkinVision app had a sensitivity of 95% in detecting the most common forms of the disease and a specificity of 78%.
AI and Analytics
The practices have both introduced the Dermicus app, which was created by Swedish company, Gnosco which recently teamed up with an AHSN in Wessex.